Skip to search formSkip to main contentSkip to account menu

Extensively Drug Resistance Process

Known as: EXTENSIVE DRUG RESISTANCE, XDR 
Resistance to nearly all known drugs, particularly the most efficacious or non-first line drugs, used in the treatment of a particular disease.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Drug Resistance Status TerminologyClinical Data Interchange Standards Consortium TerminologyPharmacologic Substance

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Antibiotic pressure on the acquisition and loss of antibiotic resistance genes in Klebsiella pneumoniae
Objectives In this study, we characterize a concurrent disseminated infection with a virulent hypermucoviscous (HMV) Klebsiella… 
Highly Cited
2014
Highly Cited
2014
Colistin nephrotoxicity increases with age
Abstract Background: Colistin (COL) has become the backbone of the treatment of infections due to extensively drug-resistant (XDR… 
2014
2014
Effectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetobacter baumannii in a Thai…
Highly Cited
2012
Highly Cited
2012
SUBMILLIMETER LINE SPECTRUM OF THE SEYFERT GALAXY NGC 1068 FROM THE HERSCHEL-SPIRE FOURIER TRANSFORM SPECTROMETER
The first complete submillimeter spectrum (190–670 μm) of the Seyfert 2 galaxy NGC 1068 has been observed with the SPIRE Fourier… 
2012
2012
Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion
Objective: The aim of this study was to evaluate several polymer carriers with regard to the bioavailability enhancement of… 
Highly Cited
2011
Highly Cited
2011
Effective Antibiotics in Combination against Extreme Drug-Resistant Pseudomonas aeruginosa with Decreased Susceptibility to Polymyxin B
Objective Extreme drug-resistant Pseudomonas aeruginosa (XDR-PA) with decreased susceptibility to polymyxin B (PB) has emerged in… 
Highly Cited
2009
Highly Cited
2009
Selection of Mutations To Detect Multidrug-Resistant Mycobacterium tuberculosis Strains in Shanghai, China
ABSTRACT Novel tools are urgently needed for the rapid, reliable detection of multidrug-resistant (MDR) and extensively drug… 
2009
2009
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
Tuberculosis (TB), mostly caused by Mycobacterium tuberculosis (Mtb), is one of the leading causes of death from infectious… 
2009
2009
Novel prophylactic and therapeutic vaccine against tuberculosis.
Review
2008
Review
2008
A health systems assessment of the KwaZulu-Natal tuberculosis programme in the context of increasing drug resistance.
SETTING High mortality and high transmission rates of extensively drug-resistant tuberculosis (XDR-TB) in KwaZulu-Natal Province… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)